Volume 2.39 | Oct 5

Mesenchymal Cell News 2.39, October 5, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe


Relevance of the Mevalonate Biosynthetic Pathway in the Regulation of Bone Marrow Mesenchymal Stromal Cell-Mediated Effects on T Cell Proliferation and B Cell Survival 
Bone marrow mesenchymal stromal cells can suppress T lymphocyte proliferation, but promote survival of normal and malignant B cells, thus representing a possible target for new therapeutic schemes. Herein, researchers defined the effects of cholesterol synthesis inhibitors on the interaction between these mesenchymal stromal cells and T or B lymphocytes. [Haematologica]

MesenCult®-XF Medium  
Obtain more MSCs in fewer passages with
MesenCult®-XF Medium

by STEMCELL Technologies


Interested in recruiting talented individuals? Post your career opportunities in Mesenchymal Cell News at no cost. Contact us at [email protected]


Technique to Reattach Teeth Using Stem Cells Developed at UIC
A new approach to anchor teeth back in the jaw using stem cells has been developed and successfully tested in the laboratory for the first time by researchers at the University of Illinois at Chicago. [Press release from the University of Illinois at Chicago discussing online prepublication in Tissue Engineering]

Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function in Preclinical Acute Kidney Injury Study Data Published Today
Preclinical data was published on research performed by Cytori Therapeutics showing adipose-derived stem and regenerative cells, either fresh or banked, demonstrated statistically significant improvements in animal survival and kidney function in an acute kidney injury animal model. [Press release from Cytori Therapeutics discussing online prepublication in Nephrology Dialysis Transplantation]

Defining Characteristics of Bona Fide Human iPS Cells
Speaker: Sutheera Ratanasirintrawoot, PhD Candidate
G. Daley & T. Schlaeger Labs, Harvard Medical School

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Cardiospheres Recapitulate a Niche-Like Microenvironment Rich in Stemness and Cell-Matrix Interactions, Rationalizing Their Enhanced Functional Potency for Myocardial Repair
Researchers tested the hypothesis that growing cardiac-derived cells as three-dimensional cardiospheres may recapitulate a stem cell niche-like microenvironment, favoring cell survival and enhancing functional benefit after transplantation into the injured heart. [Stem Cells]

Targeting of XIAP Combined With Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Here, researchers combine the tumor-specific apoptosis-inducing activity of TNF-related apoptosis-inducing ligand (TRAIL) with the ability of mesenchymal stem cells to infiltrate both tumor and lymphatic tissues to target primary tumors as well as disseminated cancer cells in a human pancreatic cancer mouse model. [Stem Cells]

Inhibition of Immune Synapse by Altered Dendritic Cell Actin Distribution: A New Pathway of Mesenchymal Stem Cell Immune Regulation
The aim of this work was to elucidate the immunogenic effects of bone marrow mesenchymal stem cell/dendritic cell (DC) interactions during DC activation (LPS stimulation or Ag loading). [J Immunol]

The Effects of Culture on Genomic Imprinting Profiles in Human Embryonic and Fetal Mesenchymal Stem Cells
The results suggest that regardless of stem cell origin, in vitro culture affects the integrity of imprinted gene expression in human cells. [Epigenetics]

Human Adipose Tissue-Derived Mesenchymal Stem Cells Induce Explosive T Cell Proliferation
Human adipose tissue-derived mesenchymal stem cells were cultured with nonactivated peripheral blood mononuclear cells (PBMCs) and the activation, proliferation, and function of PBMCs were examined. [Stem Cells Dev]

Mesenchymal Stem Cell Stimulation of Tissue Growth Depends on Differentiation State
This study investigated the stimulatory capacity of mesenchymal stem cells (MSCs) during osteogenesis and the impact of MSC phenotype on cartilage stimulation. [Stem Cells Dev]

Pluripotency Regulators in Human Mesenchymal Stem Cells: Expression of NANOG but not of OCT-4 and SOX-2
Transcription factors that regulate the maintenance of the pluripotent state in embryonic stem cells, including NANOG, SOX2 and OCT4, have been proposed to play a similar role also in adult stem cells, although with conflicting results. Researchers propose that activation of NANOG expression in mesenchymal stem cells is associated with, although cannot directly regulate, the transition from in vivo quiescence to adaptation to in vitro growth conditions. [Stem Cells Dev]

Fresh and Cryopreserved, Uncultured Adipose Tissue-Derived Stem and Regenerative Cells Ameliorate Ischemia-Reperfusion-Induced Acute Kidney Injury
Researchers investigated the possible renoprotection of freshly isolated, uncultured adipose tissue-derived stem and regenerative cells before and after cryopreservation in a rat ischemia-reperfusion model of acute kidney injury. [Nephrol Dial Transplant]

Genetically Modified Mesenchymal Stem Cells Induce Mechanically Stable Posterior Spine Fusion
In this study, researchers hypothesized that posterior spinal fusion achieved using genetically modified mesenchymal stem cells would be mechanically comparable to that realized using a mechanical fixation. [Tissue Eng Part A]

Amniotic Fluid-Derived MSCs Lead to Bone Differentiation When Co-Cultured With Dental Pulp Stem Cells
Researchers found that osteoblasts derived from dental pulp stem cells released large amounts of BMP-2 and VEGF into the culture medium and that those morphogens significantly upregulate RUNX-2 gene, stimulating osteogenesis. [Tissue Eng Part A]


Alphatec Spine, Inc. Releases Puregen (TM) Osteoprogenitor Cell Allograft to Facilitate Bone Regeneration and Announces First Patient Procedure Performed in the World
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced the release of its PureGen Osteoprogenitor Cell Allograft at the North American Spine Society Meeting (NASS) in Orlando, Florida. [Alphatec Spine, Inc. Press Release]


NIH Grants Will Advance Studies of the Form and Function of Proteins
The National Institutes of Health has awarded 23 grants for structural biology research totaling up to $290 million over five years. [National Institutes of Health, United States]

NCBI Launches the Database of Genomic Structural Variations
The National Institutes of Health announced the launch of a new resource, called the Database of Genomic Structural Variation, or dbVar, to help scientists understand how differences in DNA contribute to human health and disease. [National Institutes of Health, United States]

Lawmakers Introduce Bipartisan Legislation to Create Jobs and Promote Investment in Life Sciences
U.S. Representatives introduced bipartisan legislation that will provide tax incentives for small and mid-sized businesses to invest in life sciences research and development on a targeted basis. The Life Sciences Jobs and Investment Act of 2010 provides an opportunity to enhance medical innovation, life sciences education and job creation in the United States. [House of Representatives, United States]

NIH and FDA Announce Awards to Advance Regulatory Science
The National Institutes of Health will award $9.4 million over three years to support four research projects in regulatory science. This research is conducted in partnership with the U.S. Food and Drug Administration, which will contribute approximately $950,000. [National Institutes of Health and Food and Drug Administration, United States]

Tumor Microenvironment Network (TMEN) (U54) (RFA-CA-10-021) [Department of Health and Human Services, United States]

Resource Related Research Projects for Development of Animal Models and Related Materials (R24) (PAR-10-289) [National Center for Research Resources, United States]

Animal and Biological Material Resource Centers (P40) (PAR-11-001) [National Center for Research Resources, United States]

NHLBI Translational Research Implementation Program (TRIP) – Limited Competition – (P50) (RFA-HL-12-003) [National Heart, Lung, and Blood Institute, United States]

Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-24548) [National Institutes of Health, United States]

Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-24680) [National Institutes of Health, United States]

Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-24549) [National Institutes of Health, United States]

EVENTS (Listed by Date)

17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.)
October 6-9, 2010
Munich, Germany

bone-tec 2010 – International Bone-Tissue-Engineering Congress
October 7-10, 2010
Hannover, Germany

Functional Stem Cell and Regeneration
October 9-10, 2010
Kansas City, United States

New York Stem Cell Foundation 5th Annual Translational Stem Cell Research Conference
October 12-13, 2010
New York City, United States

4th International Symposium Stem Cells, Development and Regulation
October 12-14, 2010
Amsterdam, Netherlands

The American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting
October 15-19, 2010
Toronto, Canada

Stem Cells and Regenerative Medicine – New Solutions to Old Problems
October 18-20, 2010
San Antonio, United States

International Federation of Adipose Therapeutics & Science (IFATS) 2010 Conference
October 22-24, 2010
Dallas, United States

American Society for Matrix Biology (ASMB) 2010 Biennial Meeting
October 24-27, 2010
Charleston, United States

2nd Annual Stem Cells Asia and Regenerative Medicine Congress
October 26-28, 2010
Seoul, Korea

FDA Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations
November 2, 2010
North Bethesda, United States

Stem Cell Society Singapore Symposium 2010: Translating Science to Therapy
November 2-3, 2010

6th National Cancer Research Institute (NCRI) Conference
November 7-10, 2010
Liverpool, United Kingdom

9th Annual American Association for Cancer Research (AACR) International Conference: Frontiers in Cancer Prevention Research
November 7-10, 2010
Philadelphia, United States

Select Biosciences 2nd International Forum on Stem Cells (2010 IFSC)
November 12-13, 2010
Tianjin, China

The 16th International Conference of the International Society of Differentiation: From Stem Cells to Organisms
November 15-18, 2010
Nara, Japan

22nd European Organization for Research and Treatment of Cancer (EORTC)-National Cancer Institute (NCI)-American Association for Cancer Research (AACR) Symposium: Molecular Targets and Cancer Therapeutics
November 16-19, 2010
Berlin, Germany

Translational Excellence in Regenerative Medicine (TeRM) – Biophysical Stimuli and Mass Transport for Tissue Development
November 18-19, 2010
Lattrop, The Netherlands

Stem Cell Network's 10th Annual Scientific Meeting
November 22-24, 2010
Calgary, Alberta

First Berlin-Brandenburg School for Regenerative Therapies (BSRT) PhD Symposium
December 1-3, 2010
Berlin, Germany

52nd American Society of Hematology (ASH) Annual Meeting and Exposition
December 4-7, 2010
Orlando, United States

Tissue Engineering & Regenerative Medicine International Society – North America (TERMIS-NA) 2010 Annual Conference
December 5-8, 2010
Orlando, United States

The American Society for Cell Biology 50th Annual Meeting
December 11-15, 2010
Philadelphia, United States

Epithelial Plasticity and Epithelial to Mesenchymal Transition
January 21-26, 2011
Vancouver, Canada

Select Biosciences 5th Annual Stem Cells World Congress
January 24-25, 2011
San Diego, United States

Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
January 24-26, 2011
Washington, DC, United States

Keystone Symposia: Stem Cells in Development, Tissue Homeostasis and Disease
January 30-February 4, 2011
Santa Fe, United States

American Association for Cancer Research (AACR) Stem Cells, Development, and Cancer
March 3-6, 2011
Vancouver, Canada

Stem Cells, Cancer and Metastasis (C4)
March 6-11, 2011
Dillon, United States

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Europe 2010 Annual Conference
June 7-10, 2011
Granada, Spain

International Society for Stem Cell Research (ISSCR) 9th Annual Meeting
June 15-18, 2011
Toronto, Canada

Tissue Engineering & Regenerative Medicine International Society (TERMIS) 2011 Asia Pacific Meeting (TERMIS AP 2011)
August 3-5, 2011

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


Cell Therapy Technologist (Opexa Therapeutics)

Reach more than 11,000 potential candidates by posting your organization's career opportunities with Mesenchymal Cell News at no cost.

Visit here to post your career opportunities.

Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Mesenchymal Cell News: Archives  |  Events  |  Subscribe  |  Contact Us